Blog
RSS FeedPosted by Michael Wonder on 22 Oct 2020
Remdesivir’s hefty price tag ignores NIH investment in its creation
22 October 2020 - Throughout the Democratic presidential primary, candidates cast a spotlight on the broken U.S. health care system ...
Posted by Michael Wonder on 21 Oct 2020
A prescription for America’s drug pricing problem?
21 October 2020 - Sky-high prescription drug costs remains one of the most hotly contested issues in healthcare today. ...
Posted by Michael Wonder on 20 Oct 2020
Biden looks to Germany for answers on how to tackle high U.S. drug prices
20 October 2020 - With the U.S. election just two weeks away, Democratic presidential nominee Joe Biden is offering clues ...
Posted by Michael Wonder on 13 Oct 2020
Top Democrats call for watchdog to review Trump Medicare drug cards
13 October 2020 - Top-ranking Democrats want an independent watchdog to expedite a review of the Trump administration's plans to ...
Posted by Michael Wonder on 12 Oct 2020
Ambrisentan, diazepam and dexamethasone new exchange groups
9 October 2020 - From November, ambrisentan 5 mg & 10 mg tablets, diazepam,10 mg tablets and dexamethasone 1 mg/mL ...
Posted by Michael Wonder on 07 Oct 2020
Double dippers drive up drug costs
7 October 2020 - In searching for answers to why drug costs are high, we only need look at problems ...
Posted by Michael Wonder on 06 Oct 2020
Supreme Court wary of letting states regulate prescription drug 'middlemen'
6 October 2020 – The Supreme Court appeared skeptical Tuesday that states should be allowed to regulate prescription drug "middlemen," ...
Posted by Michael Wonder on 06 Oct 2020
1 October 2020 price disclosure - confirmed prices
6 October 2020 - Confirmed 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure has now been ...
Posted by Michael Wonder on 05 Oct 2020
Import German drug prices to the United States? Nein, danke.
4 October 2020 - Price controls would deny researchers funds for next generation of cures. ...
Posted by Michael Wonder on 30 Sep 2020
House panel says drug makers inflated prices to boost profits and reap bonuses
30 September 2020 - The Democrat-led reports come just weeks before Election Day, and amid efforts by President Donald Trump to ...
Posted by Michael Wonder on 30 Sep 2020
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before.
29 September 2020 - Not only has he lowered drug prices, President Trump claimed in the first 15 minutes of ...
Posted by Michael Wonder on 29 Sep 2020
Trump’s drug pricing ideas would cost taxpayers a bundle
29 September 2020 - Pharmaceutical companies, on the other hand, would stand to make a lot more money. ...
Posted by Michael Wonder on 29 Sep 2020
California to use market power in bid to lower prescription drug costs
28 September 2020 - California will attempt to use its massive market power to increase the availability and lower the ...
Posted by Michael Wonder on 28 Sep 2020
Sophisticated purchasing of pharmaceuticals: learning from other countries
28 September 2020 - In 2019 and early 2020, drug pricing in the United States was a top concern of ...
Posted by Michael Wonder on 28 Sep 2020
ICER publishes white paper on cornerstones for fair patient access to prescription drugs, launches annual assessment of US payer policies
28 September 2020 - Informed by expert input from patient groups, clinician specialty societies, payers, and life science companies, white paper ...